A recent New York Times story described a new fad: "microdosing" GLP-1 anti-obesity drugs like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound). I was asked to discuss the topic on ...

Studies suggest that semaglutide reduces heart attack and stroke and may curb addiction and more. Scientists reflect on the future of GLP-1 drugs beyond weight loss.

The demand for weight loss drugs, like Ozempic and Wegovy, has skyrocketed in the past few years despite the high cost and ...

Shares of Hershey Co. booked a double-digit percentage gain on Monday after Bloomberg reported that Oreo maker Mondelez ...

Experts are divided on the subject, however. While some suggest that even small doses of Ozempic could suppress appetite, there is little scientific data to support claims that microdosing leads to ...

Weight loss drugs such as Ozempic and Wegovy are increasingly popular among adults, who have flocked to the new medication as ...

Kennedy, Jr. will investigate the alleged connection between autism and childhood vaccines, despite many studies deeming them ...

As drugs like Ozempic and Wegovy keep flying off the shelves, more and more people are taking the drug into their own hands ...

Microdosing Ozempic, a weight-loss drug, is gaining popularity, with users claiming benefits like reduced hunger and weight ...

Some people are taking tiny amounts of weight loss medications, hoping to drop pounds while avoiding side effects. Does it ...

The Food and Drug Administration allows for licensed compounding pharmacies to make copies of certain drugs in short supply, and that has included semaglutide and tirzepatide, the main ingredients ...

By Dani Blum A new study adds to mounting evidence showing that drugs like Ozempic don’t just treat ... But a year later, a pharmacist gave her unwelcome news: The drug she was getting for ...